Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATHWAY: Tezepelumab in severe asthma
NCT02054130Phase 2Completed
- Sponsor
- MedImmune
- Start
- Dec 2013
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 2 trial of tezepelumab in asthma, sponsored by MedImmune. Started Dec 2013; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02054130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054130.